Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.
Blood. 2022 Nov 10;140(19):2053-2062. doi: 10.1182/blood.2022015403.
Blood. 2022.
PMID: 35576529
Free PMC article.
Clinical Trial.
Voxelotor treatment of a patient with sickle cell disease and very severe anemia.
Shet AS, Mendelsohn L, Harper J, Ostrowski D, Henry ER, Gwaabe E, Nichols J, Alayash AI, Eaton WA, Thein SL.
Shet AS, et al. Among authors: gwaabe e.
Am J Hematol. 2019 Apr;94(4):E88-E90. doi: 10.1002/ajh.25389. Epub 2019 Jan 8.
Am J Hematol. 2019.
PMID: 30592074
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite